Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

900904
Current price
0.6 USD 0 USD (0.00%)
Last closed 0.61 USD
ISIN CNE0000003X8
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Shanghai Stock Exchange
Capitalization 498 927 520 USD
Yield for 12 month -16.06 %
1Y
3Y
5Y
10Y
15Y
900904
21.11.2021 - 28.11.2021

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, nourishing and soothing, tonic products, cold and cough, children's medicine, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidate injection, loquat cough granules, strong loquat decoction, loquat cough capsules, jinwugutong capsules, coral ringworm jing, jingwu capsules, quantianma capsules, yindanxintai dropping pills, etc. The company was founded in 1990 and is based in Shanghai, China. Address: Changfa Building, Shanghai, China, 200003

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

31.25

Dividend Yield

Current Year

+328 360 197 USD

Last Year

+335 047 085 USD

Current Quarter

+75 160 916 USD

Last Quarter

+80 588 121 USD

Current Year

+163 957 134 USD

Last Year

+177 254 663 USD

Current Quarter

+34 168 892 USD

Last Quarter

+39 634 863 USD

Key Figures 900904

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 196 227 440 USD
Operating Margin TTM 2.65 %
PE Ratio 31.25
Return On Assets TTM 2.17 %
PEG Ratio
Return On Equity TTM 2.64 %
Wall Street Target Price
Revenue TTM 2 245 636 608 USD
Book Value 4.34 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -14 %
Dividend Yield
Gross Profit TTM 1 386 335 972 USD
Earnings per share 0.02 USD
Diluted Eps TTM 0.02 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 24.7 %
Profit Margin 2.68 %

Dividend Analytics 900904

Dividend growth over 5 years

213 %

Continuous growth

Payout Ratio 5 years average

15 %

Dividend History 900904

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 18.06.2024
Forward Annual Dividend Yield
Last Split Factor 12:10
Payout Ratio 85.23 %
Last Split Date 06.07.2015
Dividend Date

Stock Valuation 900904

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 31.25
Forward PE
Enterprise Value Revenue 1.4543
Price Sales TTM 0.2222
Enterprise Value EBITDA 17.185
Price Book MRQ 1.0196

Financials 900904

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 900904

For 52 weeks

0.37 USD 0.79 USD
50 Day MA 0.52 USD
Shares Short Prior Month
200 Day MA 0.56 USD
Short Ratio
Shares Short
Short Percent